ALFREDO
RAMOS MIGUEL
INVESTIGADOR/A DOCTOR/A PERMANENTE
Centro de Investigacion Biomedica en Red de Salud Mental
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigacion Biomedica en Red de Salud Mental (9)
2024
-
Effect of antipsychotic drugs on group II metabotropic glutamate receptor expression and epigenetic control in postmortem brains of schizophrenia subjects
Translational Psychiatry, Vol. 14, Núm. 1
-
New Origins of Yeast, Plant and Bacterial-Derived Extracellular Vesicles to Expand and Advance Compound Delivery
International Journal of Molecular Sciences, Vol. 25, Núm. 13
-
Next-Generation Proteomics of Brain Extracellular Vesicles in Schizophrenia Provide New Clues on the Altered Molecular Connectome
Biomedicines, Vol. 12, Núm. 1
-
Permissive epigenetic regulatory mechanisms at the histone level are enhanced in postmortem dorsolateral prefrontal cortex of individuals with schizophrenia
Journal of Psychiatry and Neuroscience, Vol. 49, Núm. 1, pp. E35-E44
2022
-
Late-life physical activity relates to brain tissue synaptic integrity markers in older adults
Alzheimer's and Dementia, Vol. 18, Núm. 11, pp. 2023-2035
2021
-
Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex
Pharmacological Reports, Vol. 73, Núm. 4, pp. 1122-1135
-
Proteomic identification of select protein variants of the SNARE interactome associated with cognitive reserve in a large community sample
Acta Neuropathologica, Vol. 141, Núm. 5, pp. 755-770
2019
-
Reduced SNAP25 Protein Fragmentation Contributes to SNARE Complex Dysregulation in Schizophrenia Postmortem Brain
Neuroscience, Vol. 420, pp. 112-128
2010
-
Reduced platelet G protein-coupled receptor kinase 2 in major depressive disorder: Antidepressant treatment-induced upregulation of GRK2 protein discriminates between responder and non-responder patients
European Neuropsychopharmacology, Vol. 20, Núm. 10, pp. 721-730